Just one week until DFWHC and Alexion webinar “ANDEXXA” on May 26


Just one week until the DFW Hospital Council (DFWHC) and Alexion Pharmaceuticals, Inc. webinar “Andexanet alfa Budget Impact Model” on Wednesday, May 26 from 1:00-2:00 p.m., CDT.

Join us for this complimentary virtual discussion on health economics. Using an approved model structure developed with clinical guidance, the speakers will detail the cost-effectiveness and budgetary impact of andexanet alfa on selected health outcomes and costs.

Speakers will include Kelly McNeil-Posey, director of health economics and outcomes research at Alexion; Sharon Williams, director of U.S. strategic accounts at Alexion; and Stephen Love, president/CEO of DFWHC.

You can register here.

For information, please contact Chris Wilson at chrisw@dfwhc.org.